Literature DB >> 2449174

Neutrophil association and degradation of normal and acute-phase high-density lipoprotein 3.

E G Shephard1, F C de Beer, M C de Beer, M S Jeenah, G A Coetzee, D R van der Westhuyzen.   

Abstract

The interaction of normal and acute-phase high-density lipoproteins of the subclass 3 (N-HDL3 and AP-HDL3) with human neutrophils and the accompanying degradation of HDL3 apolipoproteins have been studied in vitro. The chemical composition of normal and acute-phase HDL3 was similar except that serum amyloid A protein (apo-SAA) was a major apolipoprotein in AP-HDL3 (approx. 30% of total apolipoproteins). 125I-labelled AP-HDL3 was degraded 5-10 times faster than 125I-labelled N-HDL3 during incubation with neutrophils or neutrophil-conditioned medium. Apo-SAA, like apolipoprotein A-II (apo-A-II), was more susceptible than apolipoprotein A-I (apo-A-I) to the action of proteases released from the cells. The amounts of cell-associated AP-HDL3 apolipoproteins at saturation were up to 2.8 times greater than N-HDL3 apolipoproteins; while apo-A-I was the major cell-associated apolipoprotein when N-HDL3 was bound, apo-SAA constituted 80% of the apolipoproteins bound in the case of AP-HDL3. The associated intact apo-SAA was mostly surface-bound as it was accessible to the action of exogenous trypsin. alpha 1-Antitrypsin-resistant (alpha 1-AT-resistant) cellular degradation of AP-HDL3 apolipoproteins also occurred; experiments in which pulse-chase labelling was performed or lysosomotropic agents were used indicated that insignificant intracellular degradation occurred which points to the involvement of cell-surface proteases in this degradation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2449174      PMCID: PMC1148637          DOI: 10.1042/bj2480919

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Lipoprotein uptake and metabolism by rat aortic smooth muscle cells in tissue culture.

Authors:  E L Bierman; O Stein; Y Stein
Journal:  Circ Res       Date:  1974-07       Impact factor: 17.367

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The degradation of serum amyloid A protein by activated polymorphonuclear leucocytes: participation of granulocytic elastase.

Authors:  S L Silverman; E S Cathcart; M Skinner; A S Cohen
Journal:  Immunology       Date:  1982-08       Impact factor: 7.397

5.  Elastase-type proteases on the surface of human blood monocytes: possible role in amyloid formation.

Authors:  G Lavie; D Zucker-Franklin; E C Franklin
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

6.  Standardisation of the quantitation of serum amyloid A protein (SAA) in human serum.

Authors:  N L Godenir; M S Jeenah; G A Coetzee; D R Van der Westhuyzen; A F Strachan; F C De Beer
Journal:  J Immunol Methods       Date:  1985-11-07       Impact factor: 2.303

7.  Amyloid protein SAA is associated with high density lipoprotein from human serum.

Authors:  E P Benditt; N Eriksen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

8.  Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy.

Authors:  R Kisilevsky; L Boudreau; D Foster
Journal:  Lab Invest       Date:  1983-01       Impact factor: 5.662

9.  Cytolytic effects of neutrophils: role for a membrane-bound neutral proteinase.

Authors:  S Pontremoli; E Melloni; M Michetti; O Sacco; B Sparatore; F Salamino; G Damiani; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1.

Authors:  G Ramadori; J D Sipe; C A Dinarello; S B Mizel; H R Colten
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

View more
  10 in total

1.  SAA: a link between cholesterol efflux capacity and inflammation?

Authors:  Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2015-06-15       Impact factor: 5.922

2.  Apolipoprotein serum amyloid A down-regulates smooth-muscle cell lipid biosynthesis.

Authors:  B M Schreiber; M Veverbrants; R E Fine; J K Blusztajn; M Salmona; A Patel; J D Sipe
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

3.  Phosphorylation of human serum amyloid A protein by protein kinase C.

Authors:  A E Nel; M C De Beer; E G Shephard; A F Strachan; M L Vandenplas; F C De Beer
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

4.  High interleukin-6 plasma levels are associated with low HDL-C levels in community-dwelling older adults: the InChianti study.

Authors:  Giovanni Zuliani; Stefano Volpato; Alessando Blè; Stefania Bandinelli; Anna Maria Corsi; Fulvio Lauretani; Giuseppe Paolisso; Renato Fellin; Luigi Ferrucci
Journal:  Atherosclerosis       Date:  2006-06-19       Impact factor: 5.162

5.  Apolipoproteins A-I and A-II downregulate neutrophil functions.

Authors:  Cristiane Jaciara Furlaneto; Fernanda Pereira Ribeiro; Elaine Hatanaka; Glaucia Mendes Souza; Marco A Cassatella; Ana Campa
Journal:  Lipids       Date:  2002-09       Impact factor: 1.880

Review 6.  Regulation of serum amyloid A protein expression during the acute-phase response.

Authors:  L E Jensen; A S Whitehead
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

7.  Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.

Authors:  W Pruzanski; F C de Beer; M C de Beer; E Stefanski; P Vadas
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

8.  The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection.

Authors:  Ashraf Mohamadkhani; Kourosh Sayemiri; Reza Ghanbari; Elham Elahi; Hossein Poustchi; Ghodratollah Montazeri
Journal:  Virol J       Date:  2010-09-14       Impact factor: 4.099

9.  Identification in milk of a serum amyloid A peptide chemoattractant for B lymphoblasts.

Authors:  Berardo de Jesus Rodriguez; Claire Chevaleyre; Gwénaële Henry; Daniel Mollé; Isabelle Virlogeux-Payant; Mustapha Berri; François Boulay; Joëlle Léonil; François Meurens; Henri Salmon
Journal:  BMC Immunol       Date:  2009-01-23       Impact factor: 3.615

10.  Trypanosome lytic factor, an antimicrobial high-density lipoprotein, ameliorates Leishmania infection.

Authors:  Marie Samanovic; Maria Pilar Molina-Portela; Anne-Danielle C Chessler; Barbara A Burleigh; Jayne Raper
Journal:  PLoS Pathog       Date:  2009-01-23       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.